English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Published by United Scientific Group In a recent article Kirschenbaum et al., described a 50 years female with sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome due to the mutation c.467A>T in the POLG1 gene [1]. SANDO, first described by Fadic et al. in 1997 [2], is clinically characterized by the triad of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis [3]. We have the following comments and concerns.

POLG1/ANT1-Related SANDO is a Multisystem Mitochondrial Disorder